Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) program

Publication | Closed Access

DOI

233

Citations

References

2010

Year

Christopher M. O’Connor, Alan B. Miller, John E. Blair, Marvin A. Konstam, Patricia Wedge, Maria Cecilia Bahit, Peter E. Carson, Markus Haass, Paul J. Hauptman, Marco Metra,

American Heart Journal

Heart FailureCardiogenic ShockCardiovascular DiseaseVentricular Ejection FractionCardiac CareMedicineCardiologyDiastolic FunctionAnesthesiologyVasopressin Antagonism